Baxter Heparin Case Highlights Global Supply Chain Vulnerabilities
This article was originally published in The Pink Sheet Daily
Executive Summary
Correct paperwork no guarantee even legitimate API manufacturers operate according to Chinese govt. standards, chemical exec says.